Global Crohn’s Disease Drugs Market Growth 2023-2029

Global Crohn’s Disease Drugs Market Growth 2023-2029

Crohn’s disease (CD) is a form of inflammatory bowel disease (IBD), which is comprised of two chronic autoimmune diseases that cause intestinal inflammation: Crohn’s disease (CD) and ulcerative colitis (UC). The pathophysiology of CD is complex, as the disease is characterized by recurring flares that evolve along with periods of inactivity and remission.

LPI (LP Information)' newest research report, the “Crohn’s Disease Drugs Industry Forecast” looks at past sales and reviews total world Crohn’s Disease Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Crohn’s Disease Drugs sales for 2023 through 2029. With Crohn’s Disease Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Crohn’s Disease Drugs industry.

This Insight Report provides a comprehensive analysis of the global Crohn’s Disease Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Crohn’s Disease Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Crohn’s Disease Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Crohn’s Disease Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Crohn’s Disease Drugs.

The global Crohn’s Disease Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Crohn’s Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Crohn’s Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Crohn’s Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Crohn’s Disease Drugs players cover Bayer AG, Amgen, Takeda Pharmaceutical, AbbVie, UCB, Ferring, Eli Lilly, Hoffman-La Roche and Bristol-Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Crohn’s Disease Drugs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Anti-Inflammatory
Immune system suppressors
Antibiotics
Others

Segmentation by application
Hospitals
Clinics
Hospitalshospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer AG
Amgen
Takeda Pharmaceutical
AbbVie
UCB
Ferring
Eli Lilly
Hoffman-La Roche
Bristol-Myers Squibb
Pfizer

Key Questions Addressed in this Report

What is the 10-year outlook for the global Crohn’s Disease Drugs market?

What factors are driving Crohn’s Disease Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Crohn’s Disease Drugs market opportunities vary by end market size?

How does Crohn’s Disease Drugs break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.